International Journal of Inflammation

Research Article

Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain

Figure 2

6-month medical treatment costs for patients in remission (a), low disease activity state (b), and moderate to high disease activity (c), excluding biological drug costs (in Euros).
727634.fig.002a
(a) 6-month medical treatment costs for patients in remission (excluding biological drug costs)
727634.fig.002b
(b) 6-month medical treatment costs for patients in LDAS (excluding biological drug costs)
727634.fig.002c
(c) 6-month medical treatment costs for patients in moderate to high disease activity state (excluding biological drug costs)